PHG · Koninklijke Philips NV
Market Cap
$24.40B
Shares
977.43M
Volume · Oct 2
836.27K
Avg daily vol (3M)
973.64K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$23.92
Open$24.00
Day$23.78–24.02
52W close$23.81–32.91
Avg vol 30d773K
Short int2.6M · 0.3% float · 3.4d
Short vol48%
Last earningsJul 28, 2026
DataJan 2020–Oct 2026
Up next
Next earnings call
Oct 28, 2026
Est · unconfirmed
· in 4 wks
call held Jul 28, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-1.0%
Year over year
Operating margin
8.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+4.1%
Year over year · more shares
Price change (1Y)
-13.9%
Trailing year
Short interest
0.3%
Latest settlement · 3.4 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Low
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−13%
below
Price vs 50-day avg
−8%
below
RSI (14)
32
neutral
MACD trend
Negative
52-week position
1%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−8%
trailing
6-month return
−16%
trailing
YTD return
−12%
this year
Relative strength
−28%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $26 › 200d $27 — 200d above 50d
Institutional flow
Distributing
3 of 365 funds reported for Sep 30 · net -771 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.27% of float · ▲ +9.1% MoM · 3.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
365 holders — near 3-yr high, broad support
Squeeze score
43
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
29%
annualized · 1-yr
Max drawdown
−28%
past year
ATR
1.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the Earnings Call filed Jul 28, 2026
Adjusted EBITDA margin
· full year
Non-GAAP
12.5% – 13%
Adjusted EBITDA margin (including tariff refund)
· full year
Non-GAAP
13.5% – 14%
Comparable sales growth range
· full year
3% – 4.5%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−13%
Bearish
Price vs 50-day avg
−8%
Bearish
RSI (14)
32
Neutral
MACD trend
Negative
Bearish
52-week position
1%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $26 › 200d $27 — 200d above 50d
Institutional flow
Distributing
3 of 365 funds reported for Sep 30 · net -771 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.27% of float · ▲ +9.1% MoM · 3.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
365 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $24
Now $24 · 1%
Range high $33
vs 200-day avg -13%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PHG
this stock
Koninklijke Philips NV
|
$24.40B | -11.7% | — | — | 0.3% |
|
ABT
Abbott Laboratories
|
$174.90B | -22.2% | +5.7% | 28.1 | 1.1% |
|
MDT
Medtronic plc
|
$113.38B | -10.1% | +8.4% | 21.8 | 1.3% |
|
SYK
Stryker Corp
|
$104.47B | -21.6% | +11.2% | 28.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$63.59B | -55.3% | +12.5% | 17.8 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PHG | -4.2% | -8.2% | -16.2% | -2.1% | -11.7% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -4.0% | -7.7% | -28.4% | -3.0% | -24.5% |